Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,753
datasets available to search
ShareScore release 0.9.0
Dataset results
2,753 results for “NSCLC”
Shenlingcao Oral Liquid for Patients With Stage II or IIIA NSCLC
ClinicalTrials.gov study NCT03712969. IPD Sharing: NO. Countries: 1. Publications: 1.
NeoTRACK - Dissection of IO Efficacy in NSCLC by Longitudinal tracKing
ClinicalTrials.gov study NCT05825625. IPD Sharing: NO. Countries: 1. Publications: 1.
Afatinib vs Erlotinib as 2nd TKI After Failure to 1st TKI and Chemotherapy for Metastatic NSCLC
ClinicalTrials.gov study NCT02625168. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Icotinib as Adjuvant Therapy Compared With Standard Chemotherapy in Stage II-IIIA NSCLC With EGFR-mutation
ClinicalTrials.gov study NCT02448797. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Radiotherapy for NSCLC to a Individualized MLD
ClinicalTrials.gov study NCT00573040. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Phase II Study of Radiotherapy Followed by Durvalumab and Ceralasertib in Stage III NSCLC Patients With Thoracic Relapses +/- Oligometastases After PACIFIC Regimen
ClinicalTrials.gov study NCT06680050. IPD Sharing: UNDECIDED. Countries: 2. Publications: 1.
Phase II Randomized Study on Locally Advanced NSCLC Escalated Dose on Individual Basis Treatment With Radiochemotherapy
ClinicalTrials.gov study NCT01664663. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Pemetrexed +/- Carboplatin as Second Line Treatment in NSCLC
ClinicalTrials.gov study NCT00786331. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Pembrolizumab in First Line Treatment of Advanced NSCLC Patients With PD-L1 Low Tumors.
ClinicalTrials.gov study NCT03447678. IPD Sharing: NO. Countries: 1. Publications: 88.
Analysis of Re-biopsy Specimens in Advanced NSCLC With Acquired Resistance of EGFR-TKI Targeted Therapy
ClinicalTrials.gov study NCT03309462. IPD Sharing: NO. Countries: 1. Publications: 1.
Epidemiologic Multicenter Prospective Study in Advanced NSCLC (Non Small Cell Lung Cancer) Patients With PDL1 (Protein Death Ligand 1) Expression.
ClinicalTrials.gov study NCT02785562. IPD Sharing: NO. Countries: 1. Publications: 2.
Pharmacogenomic Study for Providing Personalized Strategy to the Treatment of Non-small Cell Lung Cancer (NSCLC) IIIB/IV
ClinicalTrials.gov study NCT01003964. IPD Sharing: Not stated. Countries: 1. Publications: 1.
CS-7017 in Combination With Erlotinib in Subjects With Stage IIIb/IV Non-small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT01199068. IPD Sharing: YES. Countries: 1. Publications: 0.
Locally Invasive NSCLC Treated With NEo-Adjuvant Stereotactic Body RadioTherapy and REsection
ClinicalTrials.gov study NCT02433574. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Hypofractionated Versus Conventional Chemoradiotherapy Followed by Consolidative Immunotherapy in Locally Advanced NSCLC
ClinicalTrials.gov study NCT07052669. IPD Sharing: Not stated. Countries: 1. Publications: 11.
Predictive Biomarker for Efficacy and Safety of Combination of Chemotherapy and Tislelizumab in NSCLC
ClinicalTrials.gov study NCT05244837. IPD Sharing: NO. Countries: 1. Publications: 1.
Three Modalities of Treatment in Operable and Resectable Stage IIIA (T1-3, N2) Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT00198367. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Taletrectinib Phase 2 Global Study in ROS1 Positive NSCLC
ClinicalTrials.gov study NCT04919811. IPD Sharing: Not stated. Countries: 9. Publications: 2.
GEMINI-NSCLC: NSCLC Biomarker Study
ClinicalTrials.gov study NCT05236114. IPD Sharing: Not stated. Countries: 1. Publications: 58.
VARGADO - Vargatef in 2nd-line Therapy of Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT02392455. IPD Sharing: YES. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.